Final version - G4N supplement (print version)

Dipeptidyl peptidase-4 inhibitors—still a major player in type 2 diabetes care

Commissioned by Boehringer Ingelheim Limited

This promotional supplement has been commissioned and funded by Boehringer Ingelheim Ltd and developed in partnership with Guidelines for Nurses.
View Trajenta® (linagliptin) prescribing and adverse event reporting information
PC-GB-103453  Date of preparation: January 2021

G4N Index Image

The re-usable Respimat® Soft Mist inhaler

Commissioned by Boehringer Ingelheim Limited

This promotional supplement has been commissioned and funded by Boehringer Ingelheim Ltd and developed in partnership with Guidelines for Nurses.
View prescribing information
PC-GB-103143 November 2020

Mylan HRT evidence update cover

The importance of the progestogenic component of hormone replacement therapy in women with a uterus

Funded by Mylan

Dr John Stevenson and Dr Sophia Tsiligiannis discuss progestogen prescribing in hormone replacement therapy.